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ABSTRACT: Biomimetics is a design principle within chemistry,
biology, and engineering, but chemistry biomimetic approaches
have been generally limited to emulating nature’s chemical toolkit
while emulation of nature’s physical toolkit has remained largely
unexplored. To begin to explore this, we designed biophysically
mimetic microfluidic reactors with characteristic length scales and
shear stresses observed within capillaries. We modeled the effect of
shear with molecular dynamics studies and showed that this
induces specific normally buried residues to become solvent
accessible. We then showed using kinetics experiments that rates of
reaction of these specific residues in fact increase in a shear-
dependent fashion. We applied our results in the creation of a new
microfluidic approach for the multidimensional study of cysteine
biomarkers. Finally, we used our approach to establish dissociation of the therapeutic antibody trastuzumab in a reducing
environment. Our results have implications for the efficacy of existing therapeutic antibodies in blood plasma as well as suggesting in
general that biophysically mimetic chemistry is exploited in biology and should be explored as a research area.
■ INTRODUCTION
Biomimetics, the emulation of nature’s elements, models, and
systems to solve human problems, is a key principle in many
scientific fields including chemistry,1 biology,2 and engineer-
ing.3 Within chemistry, most biomimetic research to date has
focused on exploiting nature’s chemical toolkit.4 For example,
biomimetic chemical reactions have allowed advances in the
development biologically inspired synthetic transformation
reactions, in the use of mild, aqueous reactions, as well as in
the use of biological cofactors.5−9 However, within nature,
biomolecules are subjected to distinct and variable conditions
and forces which modulate their function. For example,
biomolecules are frequently crowded or confined to small
length scales, both of which can either promote or limit
aggregation.10,11 Additionally, the elasticity of the extracellular
matrix has been shown to control stem cell lineage
specification.12 Proteins within fibroblasts are subjected to
contractile forces as the fibroblast pulls the cell body forward in
a crawling motion through 3D tissue.13 As another example,
shear stress within the circulatory system has been shown to
alter the signaling pathways of endothelial cells via a
mechanosensory complex,14 with higher shear stress generally
associated with lower risk of artherosclerosis.15 Shear stress
occurs when forces acting on a single body, such as a cell or a
protein, pull it in different directions at the same time. Shear
stress has also been shown to promote post-translational
modifications, specifically S-nitrosylation.16 Yet, redeployment
of nature’s physical architecture as a chemical tool remains
largely unexplored.
We begin to explore the use of biophysically mimetic forces
by considering shear stress experienced within capillaries. We
consider this from both computational and experimental
perspectives. A number of computational techniques which
include Brownian dynamics and lattice-Boltzmann molecular
dynamics (MD) have been developed to model the structural
effect of shear stress on biomolecules.17−19 The methods were
used to investigate flow-induced unfolding of a β-barrel protein
in different types of flows20 and stretching of integrin and
ubiquitin.20−22 In a coarse-grained MD study, the unfolding of
a β-hairpin, a WW domain, and a calcium-binding domain was
reported.18 A similar coarse-grained approach was used to
study the aggregation of several amyloidogenic peptides in
silico.23
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Here, we follow two different approaches to investigate the
dynamics of biomolecules under these nonequilibrium
conditions. In the first, proteins undergo a simple shear
flow24 that causes an increase in friction due to random
collisions of the protein with nearby solvent or other solute
molecules that exhibit rotational-translational diffusion. This
computational approach has recently been applied to under-
stand the rheo-NMR experiments performed on several
proteins at the atomic level.24 Alternatively, we perform
steered MD simulations (SMD).25,26 In these calculations, we
apply a force to two specific atoms that allows them to move
from an initial position, given by the solved X-ray structure, to
a position that we choose arbitrarily.27,28 In all calculations,
one of the atoms chosen is the Cα of the cysteine residue or
the Cα or a residue in close proximity to it (see the Supporting
Information for details). It is important to note that this
external force does not represent a shear stress induced by the
solvent and ion molecules. However, the two specified atoms
were chosen to capture significant conformational changes
around the cysteine residue through trajectories with a short time
scale. Thus, this simple strategy allows us to mimic to a certain
degree the deformation of the proteins subjected to shear flow.
SMD simulations have been used to study amyloid fibril
properties,29 dissociation and association in response to
shear,30 the importance of hydrogen bonding in protein
conformational locks,31 and protein unfolding,32 among others.
The shear flow simulations and SMD simulations provide
complementary views of the dynamics of biomolecules. In
general, the application of both of these two computational
approaches agree in showing marked increases in the solvent
Figure 1.MD simulations of BSA in a shear flow. (a) Location of free Cys34 (in red), disulfide bonded Cys (in yellow), Lys (in blue), and Trp (in
green) residues within BSA. (b) Average SASA along 100 ns conventional MD trajectory for these residues within BSA. (c) Evolution of root-
mean-square displacement (RMSD) values of Cα atoms of BSA along conventional MD and MD where the protein undergoes a shear flow (2.14 ×
106 Pa). (d) Representative snapshots derived from 100 ns (MD simulations + shear flow) of BSA. (e) Average SASA values derived from 100 ns
conventional trajectory (plain plot) or mimicking a shear flow (striped plot, shear stress 2.14 × 106 Pa) for free Cys34, disulfide bonded Cys, Lys,
and Trp residues of BSA.
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accessible surface area (SASA) of certain residues, specifically
free cysteine residues, rather than global protein unfolding.
We next study the impacts of this increase in SASA within a
microfluidic system we designed to replicate the shear stress
that has been measured in human capillaries, providing a
minimal model of an artificial capillary. Within biological
systems, proteins are subjected to considerable shear stress
(ranging from force per unit area of 0.28 Pa in postcapillary
venuoles to 9.55 Pa in the smallest diameter capillaries).33 A
maximal shear stress of 9.55 Pa is considerably higher than
shear stresses which have been shown to control the
aggregation of silk proteins.34 The fluid flow rate throughout
the diameter of the capillary varies, with the highest fluid flow
rate at the middle of the capillary and a zero fluid flow rate at
the capillary walls. Shear stress is maximal at the capillary walls
because the force differential is maximal there. Microfluidic
systems have the key advantage of being able to replicate this
behavior under laminar flow conditions.35 Microfluidic systems
further allow transformation between space and time for
precise kinetics measurements together with a convenient
optical readout.35 Hence, we survey the range of shear stresses
and associated forces acting on biomolecules within a capillary
length scale microfluidic system we designed to replicate the
range of shear stresses and forces within human capillaries.
Specifically, having observed increases in SASA of particular
residues within our MD studies, we develop an approach to
test the effects of this increased solvent accessibility on the
rates of reaction of these and other residues. We observe that
exclusively the residues for which SASA is increased on
application of the shear-mimicking steering force experience
increases in reaction rates, which shows the dependency on the
level of shear applied in the capillary length scale microfluidic
device.
In order to demonstrate how this finding provides a
dependence of specific reaction rates on shear stress that can
be used, we exploit the achieved accelerated reaction rates in a
microfluidic, multidimensional cysteine biomarker assay which
permits quantitative study of free and disulfide bonded
cysteine residues as this relates to biomolecular size. Finally,
we use our assay to monitor the structural changes catalyzed by
chemical events within the heterooligomeric therapeutic
antibody trastuzumab, with our results suggesting dissociation
under reducing conditions such as blood plasma. We expect
our portable and affordable method to find application in the
study of disease biomarkers and to enable the study of
biologics not prone to such dissociation within blood plasma.
Furthermore, we expect our study to prompt establishment
and exploration of biophysically mimetic chemistry, chemical
biology, and biochemistry, in which the variety of forces
utilized by nature to alter biomolecular behavior can be
exploited for human purposes.
■ RESULTS AND DISCUSSION
High shear stresses of up to 9.55 Pa have been measured
within human capillaries.33 We questioned what impacts these
may have on proteins transported through the capillary system
and whether any impacts could be exploited as a biophysical
tool.
Nonequilibrium MD Simulations Probe Dynamic
Changes on Application of Shear-Mimicking Steering
Force. To study the effect that shear stress has on the protein
structure at the atomic level, we first accomplished MD
simulations that mimic a simple shear flow (named Couette
flow)24 on several proteins, including albumin (BSA), β-
Lactoglobulin (β-Lac), β-galactosidase (BLG), and a full
length IgG antibody (Tras), as show in Figure 1 and
Supporting Fig.s 2−5. We considered the albumin case was
well suited to additional study on the effects of capillary
transport because it is the most abundant serum protein, is
highly conserved, is not glycosylated, and has a single
conserved free cysteine residue (Cys34) which has been
shown to undergo S-nitrosylation and be involved in a binding
site for small molecules transported by albumin.36 The
positions of this residue and other disulfide bonded cysteine
residues are shown in Figure 1a. We additionally include the
positions of lysine resides, another type of residue prone to
post-translational modifications, and intrinsically fluorescent
tryptophan residues which can be indicative of changes to the
structure of the aromatic protein core.37
First, 0.5 μs MD simulations of BSA protein at equilibrium,
with no shear stress applied, revealed that the SASA values of
lysine residues were significantly higher relative to the other
residues considered (Figure 1a and Supporting Fig. 1).
Subsequently, this protein was subjected to 100 ns MD
simulations, in which a shear flow of 1.10 × 10−7 nm ps−1
(shear stress = 9.4 Pa, Supporting Fig. 5) was applied to mimic
the experimental shear stress (up to 9.55 Pa, see below). This
resulted in the random diffusional motion of the protein rather
than structural changes, probably due to the short simulation
time.24 In fact, structural fluctuations and partial unfolding of
certain regions of BSA protein were observed only when the
theoretical shear stress was set to 2.14 × 106 Pa (Figure 1c,d).
A similar scenario was observed for the rest of the studied
proteins (Supporting Fig.s 2−5). Under these higher shear
stress conditions, we observe a 1.5-fold increase in the SASA
value of Cys34 (Figure 1e). This marked increase in SASA was
observed exclusively in the nonequilibrium MD simulations
and not in the equilibrium (or conventional) MD simulations
which were carried out using the same methods but without
the introduction of the external shear flow. Moreover, we
quantitatively confirmed that a free cysteine SASA increase was
positively related to the shear stress (Supporting Fig. 5). An
increase in SASA values was also obtained for intrinsically
fluorescent Trp residues (1.4-fold) under these high shear
stress conditions, while there were still no significant changes
observed for Lys and disulfide bonded Cys residues. Similarly,
an increase in the SASA value was observed for free Cys
residues in BLG and β-Gal (Supporting Fig.s 2 and 3,
respectively). In these cases, the MD simulations showed a
lower SASA value for disulfide bonded Cys residues relative to
MD simulations without a shear flow.
Alternatively, BSA, BLG, β-Gal, and a full length IgG
antibody were also subjected to SMD simulations (Supporting
Fig.s 6−12) and gave qualitatively similar results in terms of
SASA values. The SMD simulations allowed us to assess a
regime somewhat closer (force generally less than 200 pN for
BSA, as shown in Supporting Fig. 8) to the experimental values
and still observe changes within the short time scale of the
SMD trajectory. Interestingly, using this technique with BSA
protein, an increase in the SASA value was observed only for
Cys34 residue (1.3-fold increase relative to conventional MD
simulations). Although nonequilibrium molecular dynamics
simulations have been used to study changes in protein
structure previously, we questioned whether the increased
solvent accessibility we had observed for the free cysteine
residues may be able to be exploited to allow a faster reaction
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under biophysically mimietic conditions, for example, by
removing a steric barrier or enhancing the nucleophilic
character of the thiol group.
Reaction Rate Acceleration Dependence on Shear in
Artificial Capillary Device. To test whether this increased
surface accessibility results in more rapid reactivity, we
performed kinetics experiments within a microfluidic device
designed to provide the shear stress and forces that have been
measured within capillaries. Within microfluidic systems, fluid
is constrained to networks of small channels with characteristic
length scales similar to biological structures.38 We exploited
this feature in order to design our microfluidic device (Figure
2a) to survey the range of shear stresses within capillaries33
(0.28 to 9.55 Pa, Figure 2b) and apply corresponding levels of
force (8.04 × 10−5 to 2.74 × 10−3 pN, Figure 2c) to a protein.
Cys34, for which we had observed a marked increase in
SASA under shearing (Figure 1e) and shear mimicking
(Supporting Fig. 9) conditions in our simulations, is a
biomarker of oxidative stress,39 kidney disease, and diabetes
mellitus.40 Oxidation of Cys34 occurs based on reaction with
natural disulfides and thiols without enzymatic support,41 with
the Cys34 reduction state playing a key role in the binding of
small molecules transported by albumin.36 This allowed us to
capture biologically relevant changes in the behavior of Cys34
as it is exposed to controlled shear and monitor these changes
optically by trapping the reactive thiolate form with an
electrophilic fluorogenic dye, 4-fluoro-7-sulfamoylbenzofura-
zan (ABD-F).42 By controlling our minimal microfluidic
capillary model, we were able to tune precisely the shear
stress and force applied to Cys34 within the capillary range by
varying the microfluidic device height and fluid flow rate. For
example, as the device height decreased from 50 to 25 μm at a
constant flow rate of 25 L
h
μ , shear stress increased from 0.65 to
2.16 Pa. We observed that as the device height decreases by a
Figure 2. Biophysically mimetic shear and kinetics measurements. (a) Capillary scale kinetics device, in which optical fluorescence measurements
along the kinetics loop enable calculation of the rate of reaction of protein and dye. Varying the device height and flow rate surveys the range of (b)
shear stresses and (c) forces observed in human capillaries by using albumin for the force calculation. (d) Kinetics of labeling of Cys34 for 25 and
50 μm device height and (e) 25−100 μL/h flow rate. (f) Dependence of calculated pseudo-first-order reaction rate constant on shear stress, with
the linear fit rate constant = 11.1 × shear stress + 15.4, with R2 = 0.96. (g) Kinetics of appearance of fluorescence intensity in a fluorogenic lysine
labeling reaction, when moving from bulk to on-chip and (h) as a function flow rate (i) with the calculated rate constant plotted against shear
stress. (j) Intrinsic tryptophan fluorescence as a function of flow rate for BSA, free Trp, and BSA + SDS. (k) Recovery of intrinsic fluorescence
signal of BSA and BSA + SDS after the flow is stopped. All kinetic curves are averages of three separate experiments and standard deviation is
represented by the error bars. AU = arbitrary units.
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factor of 2, the rate of reaction with ABD-F increased by a
factor of 2 from 20.9 ± 1.5 M−1 s−1 to 45.2 ± 2.0 M−1 s−1
(Figure 2d). Interestingly, previous results43 had reported that
this residue is reactive only when the protein is subjected to
shear stress. However, we observed reactivity in the absence of
flow, which could be expected since the previous study used a
large fluorophore with three negative charges. Thus, the steric
crowding and electrostatic effects of labeling a buried cysteine
residue in this way are likely responsible for the observed lack
of reactivity of Cys34. In contrast, our fluorophore was
significantly smaller and had a lower net charge, which could
favor labeling of the free cysteine in the absence of flow.
To quantify the reaction rate changes we had observed
(Figure 2d,e), we plotted the reaction rate as a function of
shear stress (Figure 2f). Satisfyingly, we observe a linear
r e l a t i o n s h i p ( ( )reaction rate 11.1 s1M s kg M m= ×× × ×
( )shear stress 15.41Nm 1M s2 + × , R2 = 0.96), which indicated
that shear stress applied within our capillary scale microfluidic
kinetics device drove the measured increase in reaction rate.
As a control, we also examined any changes in reaction rates
that occurred for residues for which we had not observed a
significant increase in solvent accessibility on application of the
Figure 3. Development of cysteine biomarker assay. (a) Experiments are carried out in bulk or on-chip. (b) Fluorescence intensity as a function of
cysteine concentration for BSA, β-lactoglobulin (βLG), and alcohol dehydrogenase (ADH) under native conditions (filled triangles) and reducing
conditions with the addition of TCEP (filled circles) (b) in bulk and (c) on chip. (d) Combination of the data sets by standardizing between on-
chip and in-bulk fluorescence intensity reveals a linear fit flourescence intensity = 1.5 × cysteine concentration over 7 orders of magnitude with R2 =
0.98. (e) Reaction kinetics under native conditions (filled triangles) and with the addition of TCEP (filled circles) in bulk, (f) on chip, and (g) in
bulk after protease digestion. (h) Microfluidic biomarker device used here and in Figure 4.
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shear-mimicking steering force in our MD simulations. To
achieve this, we modified lysine residues with fluorogenic
ortho-pthalaldehyde (OPA)44,45 and monitored the effects of
applying the same levels of shear on the kinetics of the labeling
reaction (Figure 2g,h). Notably, shear stress did not
significantly affect the reaction rate for lysine residues (Figure
2i).
To further assess a possible conformational change affecting
Cys34 but not lysine residues, we examined aromatic residue
exposure by measuring the intrinsic fluorescence intensity of
tryptophan residues; this is solvatochromic with the
tryptophan local environment with fluorescence decreases
associated with a decrease in structure.46
An increase in flow rate to 200 μL/h decreased tryptophan
FI by 4% (Figure 2j) which was reversible after the flow was
stopped (Figure 2k). The fact that the small change was just
detectable over error was consistent with no large scale
structural changes observed in the MD simulation studies
under shear stress conditions (Figure 1d) as well as the lack of
significant SASA increase for tryptophan residues on
application of the steering force (Supporting Fig. 8). No
change was observed for free tryptophan in solution (Figure
2j).
Collectively, our results (Figures 1 and 2) suggest that the
force acting on a protein from the shear stress caused by
capillary transport does not induce large scale structural or
unfolding changes, as has been observed, for example, in
amyloid proteins.34,47 Instead, the shearing force acting on key
reactive residues normally buried within the protein structure
promotes local structural changes that increase the solvent
accessibility of these residues, causing them to react more
quickly. This hypothesis would elucidate the mechanism by
which shear stress has been observed to activate signaling
pathways, such as the MAPK, JNK, and ERK pathways48 as
well as suggesting that organisms can use transport through
their vascular system to modulate protein behavior through
post-translational modifications. Interestingly, transport
through the gated capillary network is under hormonal
control,49 lending further support to the idea of shear-mediated
post-translational modification modulation in response to
stimuli such as stress.
Utilizing Rapid Artificial Capillary Reaction Rate in a
Microfluidic Multidimensional Cysteine Biomarker
Tool. Our results suggested that biophysically mimetic systems
may unlock higher reaction rates. As an application, we
developed a multidimensional assay for cysteine biomarkers
that incorporates biomarker size and cysteine reduction state
across native and reducing conditions in a highly portable
microfluidic format.
To do this, we first establish a linear relationship between
free cysteine concentration (cysteine residues which are not
disulfide bonded) and fluorescence intensity (FI) of ABD-F
labeled cysteine both on chip (Figure 3b, filled triangles) and in
bulk (Figure 3c, filled triangles). Schematics of the on chip and
in bulk reactions are shown in Figure 3a. Disulfide bonded
cysteine residues are also attractive targets because they are
involved in neurodegenerative diseases, immune response,
vascular inflammation, and cancer aggressiveness.50,51 How-
ever, fluorogenically labeling these residues is challenging
because it requires liberating the thiol nucleophile without the
nucleophilic reducing agent itself reacting with the electro-
philic fluorogenic dye. We observed that in situ reduction of
cysteine disulfide bonds with Tris (2-carboxyethyl) phosphine
(TCEP) prior to reaction with ABD-F did not generate
significant background fluorescence, and the reactions in bulk
(Figure 3b, filled circles) and on chip (Figure 3c, filled circles)
both proceeded quantitatively.
Combining our data sets (Figure 3b,c) reveals that our
approach is quantitative across 7 orders of magnitude in
concentration (Figure 3d). Data, from both free and disulfide-
bonded cysteine and both on chip and bulk assay formats
across all proteins studied, all fit a single line with a high
correlation coefficient (R2 = 0.98). We performed an
unconstrained linear fit to the double logarithm of the data
and obtained the equation log y = 1.006 log x + 0.019; this
results in the linear equation y = 1.05x with no power
dependence, which indicates exceptional linearity and com-
plete conversion across free and disulfide bonded cysteine
residues and across in bulk and on chip assay formats (Figure
3d). However, addition of TCEP retarded the labeling reaction
both in bulk (Figure 3e) and on chip (Figure 3f). The reaction
rate on chip (7.9 ± 0.64 M−1 s−1) was comparable to the
reaction rate when a protease was added to the bulk reaction in
Figure 3g (9.9 ± 0.38 M−1 s−1). Increased solvent accessibility,
achieved by either microfluidic shear stress or protease
digestion, mitigated the reaction retardation effect, which
permitted rapid labeling of cysteine residues on a microfluidic
chip in real time, and enabled this on chip labeling to form part
of a larger on chip measurement strategy.
We note that although there are existing approaches for the
labeling of cysteine biomarkers,52,53 these generally require the
use of prelabeled proteins. Beneficially, the fluorogenic
(fluorescence generating) feature of our approach means that
protein prelabeling is not required, and accordingly there is no
need to purify protein from unreacted dye. Moreover, any
potential impact of the presence of the label on the protein
behavior under observation can be eliminated when particular
on-chip labeling and analysis strategies are applied. The rapid
reaction kinetics and observed quantitative nature of the
labeling reaction (Figures 1d−f and 3e,f) permitted us to
achieve specifically a latent analysis approach45 for native
microfluidic diffusional sizing in which measurement of a
labeled protein revealed the protein hydrodynamic radius (RH)
before it was labeled on chip.45
Our cysteine biomarker chip design is shown in Figure 3h.
Streams of protein and buffer flowed adjacent to one another
within the diffusion channel; mass transport of protein across
the diffusion channel was entirely due to diffusion which is
directly related to protein size (RH).
35 Smaller species diffused
further than larger species, and the detected fluorescence
intensity was ultimately related to protein size in comparison
to simulation (Supporting Fig. 17). Protein that had diffused
across the diffusion channel was labeled via ABD-F reaction at
cysteine residues, with or without the addition of TCEP and in
a buffered solution. Within the labeling loop, proteins were
exposed to shear within the capillary range explored here
(Figure 2b) of 0.44 Pa permitting rapid reaction within the on
chip labeling module. Because both protein size in a native and
reducing environment are available, our approach enables a
novel nondisruptive assessment of the structural effect of
protein disulfide bond cleavage.
We validate our assay by measuring proteins and protein
complexes that vary in molecular weight, structure, and
oligomeric state including dimeric BLG, monomeric BSA,
tetrameric alcohol dehydrogenase (ADH), and tetrameric β-
galactosidase (β-Gal) (Figure 4a). We observe RH, predicted
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by scaling laws54 for all globular proteins (Figure 4b) in a
native environment. RH values are comparable within error in a
reducing environment, suggesting that significant global
structural changes have not taken place. Because labeling is
quantitative, when the protein concentration is known the
fluorescence intensity depends exclusively on the number of
total or free cysteine residues within the protein. We calculate
the absolute number of cysteine residues for each protein and
protein complex detected under native and reducing
conditions and compare with expected values (Figure 4d).
All of our results match expected numbers of available
cysteines within error.
Therapeutic Antibody Dissociation in Blood-Plasma-
like Reducing Environment. Finally, having validated our
assay, we applied it to probe the behavior of a biologically
relevant system. Trastuzumab is a humanized IgG monoclonal
antibody used in the treatment of human epidermal growth
factor receptor 2 (HER2) positive breast55 and stomach56
cancers. Trastuzumab binds to the extracellular domain of
HER2, promoting internalization and downregulation of HER2
mediated cell division.57 When trastuzumab is administered via
intravenous injection, it passes through capillaries and is in a
reducing environment (blood plasma).58 We applied our assay
in order to quantify any structural changes that may occur
when trasutuzmab is placed in a reducing environment and
confined to the capillary length scale.
In a nonreducing environment, we measured an RH for
trasutuzumab which exceeds by about 25% the RH predicted
for globular proteins, as we expected given its extended
conformation. However, interestingly when trastuzumab was
placed in a reducing environment, it is measured RH decreases
from 5.0 ± 0.6 nm to 2.8 ± 0.2 nm, suggesting a dissociation
event. When trastuzumab was placed in a reducing environ-
ment, the measured absolute number of available cysteines
increased from 0 to 2. This suggested that only cysteine
residues within interchain disulfide bonds are being reduced
and labeled, and reduction of these disulfide bonds was
consistent with the apparent dissociation event.
We modeled the trastuzumab antibody, the trastuzumab half
antibody, and the heavy and light chain fragments of the
trasutuzumab half antibody (Figure 4e). While dissociation of
a hetero-oligomer like trastuzumab by definition creates a
Figure 4. Correlation of chemical and physical structural changes. (a) Crystal structures of the proteins and protein complexes used including β-
lactoglobulin (BLG), ADH, β-Gal, BSA, and Tras, with protein chains indicated colorimetrically. (b) Measured protein and protein complex
hydrodynamic radius as a function of molecular weight under native conditions. (c) Measured hydrodynamic radius for each protein and protein
complex under native and reducing conditions. (d) Absolute number of available cysteine residues measured under native and reducing conditions.
(e) Simulated Tras fragment sizes with no dissociation, half antibody dissociation, or half antibody and heavy and light chain dissociation. (f)
Average SASA values of different residues of Tras derived from 100 ns MD simulations with shear stress (8.54 × 105 Pa).
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mixture of different monomers, our diffusional assay
preferentially separates, labels, and detects the smaller species
which have diffused into the labeling region (Supporting Fig.
16). The RH we measured for trastuzumab under reducing
conditions, 2.8 ± 0.2 nm, was in agreement with the size
modeled for trastuzumab light chain fragments (2.9 nm),
suggesting trastuzumab dissociation into both half antibody
and heavy and light chain fragments. MD simulations of Tras
carried out with a shear flow (or alternatively, SMD
simulations) showed that the intermolecular disulfide bridges
(heavy and light chain) had a significantly higher SASA upon
application of shear stress than the intramolecular disulfides
(Supporting Fig.s 4 and 12), supporting the idea that these
particular disulfide bonds would have been highly accessible to
the TCEP reducing agent when shear stress was applied in the
microfluidic device. Finally, we performed native mass
spectrometry experiments to directly measure the stoichiom-
etry under reducing, shearing conditions as in our microfluidic
device and in capillaries (Supporting Fig. 18b). Satisfyingly, we
observed dissociation of the monoclonal antibody into heavy
and light chain fragments in reducing, shearing conditions, as
our experiments and simulations indicated, which was not
observed in our control experiments under nonreducing
conditions (Supporting Fig. 18a).
■ CONCLUSION
Heavy/light chain dissociation within a reducing environment,
such as blood plasma, reduces the affinity of trastuzumab and
other monoclonal antibodies.59 Our experimental and
simulation results, which we confirmed via native mass
spectrometry, suggest that trastuzumab may be dissociated
into heavy and light chain components in plasma, potentially
reducing its affinity. Further studies should use our assay to
study dissociation of trastuzumab in plasma. Our results also
suggest that in vivo fluorescence techniques, for example,
involving FRET, should be used to assess the structural
integrity of trasutzumab that has been transported through
capillaries in blood plasma. Finally, our assay can be used to
screen and identify variants of trasutzumab and other
monoclonal antibodies which do not dissociate in a reducing
environment and which may retain higher affinity in plasma.
This may be achieved by substituting heavy chains that form
disulfide bonds with higher reduction potentials. Our assay
could also be used in the study of other biologics or disease
associated cysteine biomarkers.
Our results further suggest that shear stress experienced
within microfluidic devices may modulate protein structure
and that reaction rates for some reactions may be accelerated
relative to their bulk counterparts. The research area of
nanofluidics could enable particularly rapid reactivity due to
the particularly small channel characteristic length scales and
associated high shear rates, albeit with potential structural
changes.
More broadly, we have provided a proof-of-concept
demonstration of the potential of biophysically mimetic
chemistry. We anticipate that mirroring nature and its use of
its physical architecture to modulate protein function will find
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